# Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan

Study · id `cardio:ct-nct01552954` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01552954](<https://clinicaltrials.gov/study/NCT01552954>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01552954

Browse, organ or system: Blood vessels; Kidneys  
Browse, condition area: High blood pressure; Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.

## Technical summary

Registry record NCT01552954. Randomized; no masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-06 (actual). Results posted on 2014-12-18.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 269 participants (enrolled count; ClinicalTrials.gov record NCT01552954, source copy `cardio:ctgov-nct01552954-2014-12-18`, retrieved 2026-10-26)
- Start date: 2012-02 (registry gives no type) (ClinicalTrials.gov record NCT01552954, source copy `cardio:ctgov-nct01552954-2014-12-18`, retrieved 2026-10-26)
- Primary completion: 2013-06 (actual) (ClinicalTrials.gov record NCT01552954, source copy `cardio:ctgov-nct01552954-2014-12-18`, retrieved 2026-10-26)
- Completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01552954, source copy `cardio:ctgov-nct01552954-2014-12-18`, retrieved 2026-10-26)
- Results first posted: 2014-12-18 (ClinicalTrials.gov record NCT01552954, source copy `cardio:ctgov-nct01552954-2014-12-18`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01552954, source copy `cardio:ctgov-nct01552954-2014-12-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01552954-2014-12-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan
- Acronym: ESPECIAL
- Condition: Hypertension
- Condition: Chronic Kidney Disease
- Condition: Microalbuminuria
- Intervention (Behavioral): Intensive education of low salt diet
- Lead sponsor: Seoul National University Bundang Hospital
- Lead sponsor class: OTHER
- Collaborator: Daiichi Sankyo
- Collaborator class: INDUSTRY
- Collaborator: Daewoong Pharmaceutical Co. LTD.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Seoul National University Bundang Hospital (`cardio:org-seoul-national-university-bundang-hospital`)
- Registry lists this organization as a collaborator: Daiichi Sankyo (`cardio:org-daiichi-sankyo`)
- Registry lists this organization as a collaborator: Daewoong Pharmaceutical Co. LTD. (`cardio:org-daewoong-pharmaceutical-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A low-salt diet increases the estimated net endogenous acid production in nondiabetic chronic kidney disease patients treated with angiotensin receptor blockade (`cardio:pubmed-25531146`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial (`cardio:pubmed-26098847`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants (`cardio:pubmed-37612109`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 69506ff32560384b35e0aead821a83d237a3b53adc113961e6b8a5dac547846d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
